Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial
Nephrology Dialysis Transplantation · 31.07.2023 · 38 (8) · 1823-1835
DOI: 10.1093/ndt/gfad043 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 03.03.2023. Verfasst von Angela Yee-Moon Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Chronic Kidney Disease-Mineral and Bone Disorder, Cinacalcet, Hyperparathyroidism, Secondary, Kidney Failure, Chronic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: University of Hong Kong Research, Hong Kong Society of Nephrology, Hong Kong Kidney Foundation.
Abstract (Originalsprache)
Background
This trial aimed to evaluate oral cinacalcet versus total parathyroidectomy (PTx) with forearm autografting on cardiovascular surrogate outcomes and health-related quality of life (HRQOL) measures in dialysis patients with advanced secondary hyperparathyroidism (SHPT).
Design
In this pilot prospective randomized trial conducted in two university-affiliated hospitals, 65 adult peritoneal dialysis patients with advanced SHPT were randomized to receive either oral cinacalcet or PTx. Primary endpoints were changes in left ventricular (LV) mass index by cardiac magnetic resonance imaging and coronary artery calcium scores (CACS) over 12 months. Secondary endpoints included changes in heart valves calcium scores, aortic stiffness, biochemical parameters of chronic kidney disease-mineral bone disease (CKD-MBD) and HRQOL measures over 12 months.
Results
Changes in LV mass index, CACS, heart valves calcium score, aortic pulse wave velocity and HRQOL did not differ between groups or within groups, despite significant reductions in plasma calcium, phosphorus and intact parathyroid hormone in both groups. Cinacalcet-treated patients experienced more cardiovascular-related hospitalizations than those who underwent PTx (P = .008) but the difference became insignificant after adjusting for baseline difference in heart failure (P = .43). With the same monitoring frequency, cinacalcet-treated patients had fewer hospitalizations due to hypercalcemia (1.8%) than patients who underwent PTx (16.7%) (P = .005). No significant changes were observed in HRQOL measures in either group.
Conclusions
Both cinacalcet and PTx effectively improved various biochemical abnormalities of CKD-MBD and stabilized but did not reduce LV mass, coronary artery and heart valves calcification, or arterial stiffness, or improve patient-centered HRQOL measures in PD patients with advanced SHPT. Cinacalcet may be used in place of PTx for treating advanced SHPT. Long-term and powered studies are required to evaluate PTx versus cinacalcet on hard cardiovascular outcomes in dialysis patients.
Trial registration
ClinicalTrials.gov identifier: NCT01447368.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
- Department of Medicine, Tung Wah Hospital, Hong Kong SAR, China.
- Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong SAR, China.
- Biomedical Imaging Center, Hong Kong SAR, China.
- Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Angela Yee-Moon Wang
Förderung
- University of Hong Kong Research
- Hong Kong Society of Nephrology
- Hong Kong Kidney Foundation
Zitieren
APA
Wang, A. Y., Lo, W. K., Cheung, S. C., Tang, T. K., Yau, Y. Y., & Lang, B. H. (2023). Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial. Nephrology Dialysis Transplantation, 38(8), 1823-1835. https://doi.org/10.1093/ndt/gfad043
Vancouver
Wang AY, Lo WK, Cheung SC, Tang TK, Yau YY, Lang BH. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial. Nephrology Dialysis Transplantation. 2023;38(8):1823-1835. doi:10.1093/ndt/gfad043
BibTeX
@article{Wang2023,
author = {Wang, Angela Yee-Moon and Lo, Wai Kei and Cheung, Stephen Chi-Wai and Tang, Tak-Ka and Yau, Yat-Yin and Lang, Brian Hung-Hin},
title = {Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
volume = {38},
number = {8},
pages = {1823--1835},
doi = {10.1093/ndt/gfad043}
}
EUVIMED